Health and Human Services employees aren’t the only ones out of work. Thousands of private-sector biopharma professionals ...

As the biopharma industry grapples with the uncertain macro environment brought on by the new administration, CEOs, ...

Novartis plans to build seven new facilities in the U.S., touting the creation of up to 1,000 new jobs at the company. The ...

According to analysts at Jefferies, legislation such as the newly proposed bills that aim to streamline regulatory processes ...

Analysts at William Blair expect drug developers will continue to perform “at least some animal testing” on their investigational products. Though the process to phase out animal testing will begin ...